Speciality Medicines Ltd Finalizes Arrangement with International Distributor for US$2 Million Order Booking
Speciality Medicines Ltd has announced the finalization of a commercial arrangement with an international entity. This new partnership focuses on importing and distributing the company’s Pharmaceutical Finished Products, thereby supporting the firm's future growth.Under the terms of the agreement, the international entity has committed to distributing, marketing, and selling the products of Speciality Medicines Ltd. The value of this confirmed order stands at US$2 million, which is approximately equivalent to ₹ 18.8 Crores.
This commercial arrangement is anticipated to significantly enhance the Company's distribution network and boost its revenue visibility.
The transaction involves an order received from the international entity, and the company clarified that none of its promoters, the promoter group, or group companies have any interest in the order or contract, ensuring the transaction does not constitute a related party transaction.
The details of the order booking are as follows:
| Metric | Value |
|---|---|
| Order Value (USD) | US$2 million |
| Order Value (INR, Approximate) | ₹ 18.8 Crores |
| Partner | International Entity |
| Service | Importing and Distributing Pharmaceutical Finished Products |
The agreement is expected to bolster Speciality Medicines Ltd's operational reach in the market.
Stock Price Movement
Speciality Medicines Ltd shares are edging higher as of 11:52, currently trading at ₹313.70, marking a gain of 4.99%. The stock maintained a strong intraday session, bouncing between a low of ₹311.00 and a high of ₹313.70.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.